KAIST Develops Platform to Convert Toxic Gas 'Hydrogen Sulfide' into a Therapeutic Tool
A platform has been developed that can convert hydrogen sulfide (H2S), known as a toxic gas, into a therapeutic tool.
KAIST announced on March 23 that a research team led by Professor Jimin Park of the Department of Biological Chemical Engineering has developed an electrochemical-based "hydrogen sulfide delivery bioelectronic platform" that can precisely control the generation and delivery of hydrogen sulfide at the desired time and location.
(From the top left) Professor Jimin Park, Dr. Jaewoong Lee, Master Rian Im, PhD candidate Changho Lee. KAIST
View original imageHydrogen sulfide has long been recognized as a hazardous substance with a foul odor (the smell of rotten eggs) and toxicity. However, in recent years, it has attracted attention as a "biological signaling messenger" that helps maintain cellular health and regulates protein function.
In particular, the ability of hydrogen sulfide to act as a "chemical switch," subtly altering protein structures to regulate their function, is considered a key advantage. However, its practical use in therapy has been limited because it is difficult to control its concentration and to deliver it precisely to specific areas.
The research team has addressed these challenges by developing a technology that enables precise control of hydrogen sulfide, similar to an electric switch.
Inspired by the cyclic system of bacteria in nature, the team applied electricity to thiosulfate, a biocompatible material, to generate hydrogen sulfide. Compared to conventional chemical administration methods, this approach offers higher safety and precision of control.
In addition, by comparing and analyzing various metal electrodes, the team confirmed that a silver (Ag) electrode is the most efficient material. The silver electrode enables more precise control of hydrogen sulfide production due to its ability to selectively promote the generation reaction and its high electron transfer efficiency.
According to the research team, by using this platform, it is possible to precisely control the amount and rate of hydrogen sulfide release through only the intensity and duration of the applied voltage, which allows optimal delivery to match the patient's condition or treatment area.
The research team successfully applied the platform to human-derived HEK293T cells and precisely regulated the ion channel (TRPA1), which acts as a "switch" for sensing pain and stimuli within cells, using electrical signals.
Notably, when the platform was applied to cells in an oxidative stress state (damaged by increased reactive oxygen species), the team observed a therapeutic effect, such as restoring cellular balance with hydrogen sulfide. During this process, almost no cytotoxicity was observed, confirming the platform's potential safety for use in humans.
Professor Park stated, "This study is significant in that it converted hydrogen sulfide, previously considered only a toxic substance, into a new tool for regulating biological systems through precise electrical control. The platform has strong potential for expansion not only to precision medical devices for treating neurological and cardiovascular diseases but also to the field of digital healthcare for real-time health monitoring."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, this study was co-led by Master Limrian, PhD candidate Changho Lee, and Dr. Jaewoong Lee as joint first authors, with Professor Jihan Kim as a co-author and Professor Jimin Park as the corresponding author. The research paper was published in the international journal Science Advances on March 19.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.